Home | News | Overview | Our Residents | Why LMC? | Our IM Faculty | Our Graduates | For More Information | About the Region | Fellowships | Photos | Links

Internal Medicine and Fellowship Programs

Michael Schulman, D.O.

 
Michael Schulman, D.O.
INTERNAL MEDICINE, GASTROENTEROLOGY
EDUCATION
Undergraduate: State University of New York at Binghamton
 
Medical School: University of Health Sciences College of Osteopathic Medicine
 
Internship: Sun Coast Hospital
 
Residency: Internal Medicine, Long Island Jewish Medical Center, Long Island Campus for the Albert Einstein College of Medicine
 
Fellowship: Gastroenterology and Hepatology, Tulane University Medical Center
 
PAST AND PRESENT POSITIONS
Member, Patient Education Committee, Crohn's and Colitis Foundation of America.  1993 - Present.
 
Member, Medical Education Committee, University General Hospital.  1996 - 1997.
PUBLICATIONS
Schulman MI, Donovick PJ, Burright, RG.  The effect of Toxocara Canis on the aggressive behavior of mice.  Presented at Psychology Conference at the State University of New York at Binghamton, Department of Psychology; April 1983.  Submitted for publication.
 
Kawai M, Schulman MI.  Cornacchia crossbridge kinetics of rabbit skeletal muscle fibers when the lattice space is altered by Dextran T-500 and ionic strength changes.  Biophysical Journal: 45, 7A (Abstract), 1984.
 
Feit H, Kawai M, Schulman, MI.  Stiffness and constractile properties of avian normal and dystrophic muscle bundles.  Muscle and Nerve: 8:503-510, 1985.
 
Kawai M, Schulman MI.  Crossbridge kinetics in chemically skinned rabbit psoas dibers when the actin-myosin lattice spacing is altered by Dextran T-500.  Journal of Muscle Research and Cell Motility: 6:313-332, 1985.
 
Bank S, Sosnowik D, Schulman MI.  Rectal impaction due to popcorn bezoar: Case report and review of the literature.  Submitted for publication to the American Journal of Gastroenterology, March 1988.
 
Schulman MI, Hanauer SB.  Inflammatory Bowel Disease, New Therapeutic Approaches.  To be published in Gastroenterology Clinics of North America.  Editor Mark Peppercorn, M.D., W.B. Saunders Company, September 1995.
 
Berman, AL, Hallgren SE, Schulman MI.  Phase II Diclofenac 75mg BID with Ibuprofen 80mg TID with Searle Pharmaceutical Company for the treatment of Osteo and Rheumatoid Arthritis, 1997.